Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)
Clinical trial NCT03990961 · TERMINATED
Trial details
- NCT number
- NCT03990961
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2024-04-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.